Sermorelin research vial
GHRH / GHRP

Sermorelin

GHRH(1-29)

$54.99SERMO-5

A GHRH(1-29) analog researched for pulsatile growth hormone secretion.

Commonly acquired for growth-hormone axis research. Used in studies of pituitary somatotroph stimulation and the pulsatile character of endogenous secretion.

Bundle & save

Estimated arrival Mon, September 14 – Tue, September 15 · dispatched next business day via priority shipping
Earns 54 points $1.80 toward a future order
≥99% purity guaranteed Third-party tested Lot-specific COA Next-business-day dispatch

A GHRH(1-29) analog researched for pulsatile growth hormone secretion.

Supplied as a research-use-only preparation from a cGMP-compliant, ISO-certified facility and guaranteed to a minimum of 99% purity. Each lot is submitted for independent third-party analysis, and the certificate of analysis is tied to the lot code printed on the vial you receive.

Not for human or animal consumption. This compound is intended strictly for in-vitro laboratory and scientific research use. It is not approved by the FDA and is not for medical, diagnostic, or therapeutic use.

Independent literature

Published research on Sermorelin

Peer-reviewed publications about this compound, hosted by PubMed and the original publishers. Read them there, not here.

The references below are independent, peer-reviewed publications about this compound as studied in academic and clinical research. They are provided for scientific context only. They are not evidence for any claim about this product, they do not describe this material, and their authors have no affiliation with BioStem Labs. Linking to a study is not a claim that its findings apply to anything sold here.
Sermorelin
FormulaC149H246N44O42S
Molecular weight3357.9 g/mol
PubChem CID 16132413
Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males
Transl Androl Urol2020 PMID 32257855
PEGylation of growth hormone-releasing hormone (GRF) analogues
Adv Drug Deliv Rev2003 PMID 14499707
The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration
Front Endocrinol (Lausanne)2026 PMID 42395176
Documentation

Certificate of analysis

Independent third-party analysis for the lot on your vial — opened directly, no lookup.

Certificate of analysis

Sermorelin · 10 mg · Lot CA0001

Purity
>99.80% ±0.18%
Assay
10.62 mg
Lab ID
V251008-22 002
Date reported
2026-09-03
sermorelin.pdf Vanguard Laboratory · ISO 17025:2017 · A2LA #6377.01.01
Open certificate →